A Precision Adjuvant Approach to Enhance Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines Optimized for Immunologically Distinct Vulnerable Populations( )

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has caused significant mortality, especially among older adults whose distinct immune system reflects immunosenescence. Multiple SARS-CoV-2 vaccines have received emergency use authorization and/or licensure from the US Food a...

Descripción completa

Detalles Bibliográficos
Autores principales: Dowling, David J, Levy, Ofer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Precision Vaccines Supplement
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129145/
https://www.ncbi.nlm.nih.gov/pubmed/35512145
http://dx.doi.org/10.1093/cid/ciac342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129145/
https://www.ncbi.nlm.nih.gov/pubmed/35512145
http://dx.doi.org/10.1093/cid/ciac342

Ejemplares similares